Digital Media briefs

Share this article:
WebMD launched its Medscape mobile app for iPad and Android. The app, previously available on iPhone and BlackBerry, has seen 700,000 healthcare professional registrations, and it was the top free medical app of the year for iPhone.

Nearly half of all US adults—48%, or 112 million—used the internet for drug information in 2010, according to Manhattan Research, which found that older consumers are now joining their younger counterparts in searching for medical info online. That's more than double the 55 million Americans searching for drug info online in 2005. The research firm said it found that consumers are more likely to discuss the information they glean online with their doctors than they are to act unilaterally on it, and consumers “are considerably more likely to use pharma product and corporate websites for prescription drug information than government websites, pharmacy websites, patient association websites and social media sources.”

A CVS Caremark survey of four decades of medical journal articles on how health information technology and electronic communications may impact adherence found few studies that show how HIT can be used to boost compliance.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?